TTR and amyloidosis: In liver, the Alnylam's GalNAc siRNA conjugates are aimed to silence expression of transthyretin (TTR) protein, a mutant form of which causes TTR-mediated amyloidosis (ATTR), an inherited, progressively debilitating, frequently fatal disease (Manoharan M. et al., personal communication).